Which has stronger valuation & earnings, SDGR or HSTM?

HealthStream has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 8.86 -$103.26M -$0.74 N/A HealthStream $304.06M 2.79 $18.34M $0.72 40.29

Does the media prefer SDGR or HSTM?

In the previous week, Schrodinger had 13 more articles in the media than HealthStream. MarketBeat recorded 15 mentions for Schrodinger and 2 mentions for HealthStream. Schrodinger's average media sentiment score of 0.62 beat HealthStream's score of 0.23 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthStream 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CERT or HSTM more profitable?

HealthStream has a net margin of 6.60% compared to Certara's net margin of -16.75%. HealthStream's return on equity of 6.81% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% HealthStream 6.60% 6.81% 4.64%

Does the media prefer CERT or HSTM?

In the previous week, HealthStream had 1 more articles in the media than Certara. MarketBeat recorded 2 mentions for HealthStream and 1 mentions for Certara. HealthStream's average media sentiment score of 0.23 beat Certara's score of -0.38 indicating that HealthStream is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral HealthStream 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, HSTM or GDRX?

GoodRx has higher revenue and earnings than HealthStream. HealthStream is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthStream $304.06M 2.79 $18.34M $0.72 40.29 GoodRx $796.85M 1.48 $30.44M $0.04 86.00

Is HSTM or GDRX more profitable?

HealthStream has a net margin of 6.60% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat HealthStream's return on equity. Company Net Margins Return on Equity Return on Assets HealthStream 6.60% 6.81% 4.64% GoodRx 2.07% 7.22% 2.53%

Does the media refer more to HSTM or TDOC?

In the previous week, Teladoc Health had 9 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Teladoc Health and 2 mentions for HealthStream. HealthStream's average media sentiment score of 0.23 beat Teladoc Health's score of 0.11 indicating that HealthStream is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthStream 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teladoc Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to SOPH or HSTM?

In the previous week, SOPHiA GENETICS had 2 more articles in the media than HealthStream. MarketBeat recorded 4 mentions for SOPHiA GENETICS and 2 mentions for HealthStream. HealthStream's average media sentiment score of 0.23 beat SOPHiA GENETICS's score of -0.05 indicating that HealthStream is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SOPHiA GENETICS 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HealthStream 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

HealthStream (HSTM) Competitors

$29.01 -0.07 (-0.24%)

Closing price 09/22/2026 04:00 PM Eastern

Extended Trading

$29.01 +0.00 (+0.00%)

As of 04:01 AM Eastern

Compare

HSTM vs. SDGR, CERT, GDRX, TDOC, and SOPH

Should you buy HealthStream stock or one of its competitors? HealthStream's main competitors and comparable companies include Schrodinger (SDGR), Certara (CERT), GoodRx (GDRX), Teladoc Health (TDOC), and SOPHiA GENETICS (SOPH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does HealthStream compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and HealthStream (NASDAQ:HSTM) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Schrodinger has a beta of 1.69, meaning that its stock price is 69% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

Schrodinger currently has a consensus price target of $20.50, indicating a potential downside of 33.22%. HealthStream has a consensus price target of $27.00, indicating a potential downside of 6.93%. Given HealthStream's higher probable upside, analysts clearly believe HealthStream is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

HealthStream has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	8.86	-$103.26M	-$0.74	N/A
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.29

HealthStream has a net margin of 6.60% compared to Schrodinger's net margin of -20.98%. HealthStream's return on equity of 6.81% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
HealthStream	6.60%	6.81%	4.64%

In the previous week, Schrodinger had 13 more articles in the media than HealthStream. MarketBeat recorded 15 mentions for Schrodinger and 2 mentions for HealthStream. Schrodinger's average media sentiment score of 0.62 beat HealthStream's score of 0.23 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	7 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 69.6% of HealthStream shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 20.4% of HealthStream shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

HealthStream beats Schrodinger on 9 of the 16 factors compared between the two stocks.

How does HealthStream compare to Certara?

Certara (NASDAQ:CERT) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

HealthStream has lower revenue, but higher earnings than Certara. Certara is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.22	-$1.60M	-$0.45	N/A
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.29

Certara presently has a consensus target price of $8.28, indicating a potential downside of 6.25%. HealthStream has a consensus target price of $27.00, indicating a potential downside of 6.93%. Given Certara's stronger consensus rating and higher probable upside, equities research analysts clearly believe Certara is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

74.0% of Certara shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Certara has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market.

In the previous week, HealthStream had 1 more articles in the media than Certara. MarketBeat recorded 2 mentions for HealthStream and 1 mentions for Certara. HealthStream's average media sentiment score of 0.23 beat Certara's score of -0.38 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthStream	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HealthStream has a net margin of 6.60% compared to Certara's net margin of -16.75%. HealthStream's return on equity of 6.81% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
HealthStream	6.60%	6.81%	4.64%

Summary

HealthStream beats Certara on 9 of the 17 factors compared between the two stocks.

How does HealthStream compare to GoodRx?

HealthStream (NASDAQ:HSTM) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

HealthStream has a net margin of 6.60% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat HealthStream's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.60%	6.81%	4.64%
GoodRx	2.07%	7.22%	2.53%

69.6% of HealthStream shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 20.4% of HealthStream shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

GoodRx has higher revenue and earnings than HealthStream. HealthStream is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.29
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.00

HealthStream has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market.

HealthStream presently has a consensus price target of $27.00, suggesting a potential downside of 6.93%. GoodRx has a consensus price target of $4.23, suggesting a potential upside of 22.89%. Given GoodRx's stronger consensus rating and higher probable upside, analysts plainly believe GoodRx is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

In the previous week, HealthStream had 2 more articles in the media than GoodRx. MarketBeat recorded 2 mentions for HealthStream and 0 mentions for GoodRx. HealthStream's average media sentiment score of 0.23 beat GoodRx's score of 0.00 indicating that HealthStream is being referred to more favorably in the media.

Company	Overall Sentiment
HealthStream	Neutral
GoodRx	Neutral

Summary

HealthStream and GoodRx tied by winning 8 of the 16 factors compared between the two stocks.

How does HealthStream compare to Teladoc Health?

HealthStream (NASDAQ:HSTM) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

HealthStream has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

HealthStream has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.29
Teladoc Health	$2.53B	0.46	-$200.32M	-$0.99	N/A

69.6% of HealthStream shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 20.4% of HealthStream shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Teladoc Health had 9 more articles in the media than HealthStream. MarketBeat recorded 11 mentions for Teladoc Health and 2 mentions for HealthStream. HealthStream's average media sentiment score of 0.23 beat Teladoc Health's score of 0.11 indicating that HealthStream is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

HealthStream has a net margin of 6.60% compared to Teladoc Health's net margin of -7.13%. HealthStream's return on equity of 6.81% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.60%	6.81%	4.64%
Teladoc Health	-7.13%	-12.15%	-5.83%

HealthStream currently has a consensus target price of $27.00, suggesting a potential downside of 6.93%. Teladoc Health has a consensus target price of $7.54, suggesting a potential upside of 18.82%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts plainly believe Teladoc Health is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

HealthStream beats Teladoc Health on 9 of the 16 factors compared between the two stocks.

How does HealthStream compare to SOPHiA GENETICS?

SOPHiA GENETICS (NASDAQ:SOPH) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

SOPHiA GENETICS has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

HealthStream has higher revenue and earnings than SOPHiA GENETICS. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than HealthStream, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	8.76	-$79M	-$1.15	N/A
HealthStream	$304.06M	2.79	$18.34M	$0.72	40.29

SOPHiA GENETICS currently has a consensus price target of $10.00, suggesting a potential upside of 23.92%. HealthStream has a consensus price target of $27.00, suggesting a potential downside of 6.93%. Given SOPHiA GENETICS's stronger consensus rating and higher possible upside, research analysts plainly believe SOPHiA GENETICS is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, SOPHiA GENETICS had 2 more articles in the media than HealthStream. MarketBeat recorded 4 mentions for SOPHiA GENETICS and 2 mentions for HealthStream. HealthStream's average media sentiment score of 0.23 beat SOPHiA GENETICS's score of -0.05 indicating that HealthStream is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SOPHiA GENETICS	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthStream	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

31.6% of SOPHiA GENETICS shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 4.9% of SOPHiA GENETICS shares are held by company insiders. Comparatively, 20.4% of HealthStream shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

HealthStream has a net margin of 6.60% compared to SOPHiA GENETICS's net margin of -93.86%. HealthStream's return on equity of 6.81% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%
HealthStream	6.60%	6.81%	4.64%

Summary

HealthStream beats SOPHiA GENETICS on 10 of the 16 factors compared between the two stocks.

Get HealthStream News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSTM vs. The Competition

Export

Metric	HealthStream	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$849.58M	$1.72B	$7.27B	$13.25B
Dividend Yield	0.48%	3.89%	2.53%	13.00%
P/E Ratio	40.29	21.05	274.31	25.86
Price / Sales	2.79	89.18	639.21	91.22
Price / Cash	11.16	31.68	76.31	52.02
Price / Book	2.43	6.22	10.69	6.42
Net Income	$18.34M	-$18.66M	$3.49B	$360.08M
7 Day Performance	-1.39%	1.62%	2.58%	2.79%
1 Month Performance	0.48%	2.00%	-1.80%	-2.48%
1 Year Performance	0.07%	-16.43%	18.64%	7.15%

HealthStream Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSTM HealthStream	2.4476 of 5 stars	$29.01 -0.2%	$27.00 -6.9%	-1.0%	$849.58M	$304.06M	40.29	1,160
SDGR Schrodinger	1.2037 of 5 stars	$22.75 +9.6%	$20.50 -9.9%	+55.7%	$1.68B	$259.04M	N/A	850	Insider Trade
CERT Certara	1.1134 of 5 stars	$8.26 +3.2%	$8.28 +0.3%	-24.4%	$1.26B	$421.75M	N/A	1,576
GDRX GoodRx	4.064 of 5 stars	$3.55 -0.4%	$4.23 +19.2%	-15.5%	$1.21B	$785.23M	88.65	697	Positive News
TDOC Teladoc Health	2.5575 of 5 stars	$6.62 +1.8%	$7.54 +13.9%	-22.7%	$1.20B	$2.49B	N/A	5,600	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSTM) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthStream (HSTM) Competitors

HSTM vs. SDGR, CERT, GDRX, TDOC, and SOPH

How does HealthStream compare to Schrodinger?

Summary

How does HealthStream compare to Certara?

Summary

How does HealthStream compare to GoodRx?

Summary

How does HealthStream compare to Teladoc Health?

Summary

How does HealthStream compare to SOPHiA GENETICS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSTM vs. The Competition

HealthStream Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthStream (HSTM) Competitors

HSTM vs. SDGR, CERT, GDRX, TDOC, and SOPH

How does HealthStream compare to Schrodinger?

Which has more volatility & risk, SDGR or HSTM?

Do analysts prefer SDGR or HSTM?

Which has stronger valuation & earnings, SDGR or HSTM?

Is SDGR or HSTM more profitable?

Does the media prefer SDGR or HSTM?

Do insiders and institutionals have more ownership in SDGR or HSTM?

Summary

How does HealthStream compare to Certara?

Which has preferable earnings and valuation, CERT or HSTM?

Do analysts recommend CERT or HSTM?

Do institutionals & insiders believe in CERT or HSTM?

Which has more volatility and risk, CERT or HSTM?

Does the media prefer CERT or HSTM?

Is CERT or HSTM more profitable?

Summary

How does HealthStream compare to GoodRx?

Is HSTM or GDRX more profitable?

Do insiders & institutionals have more ownership in HSTM or GDRX?

Which has preferable earnings & valuation, HSTM or GDRX?

Which has more volatility & risk, HSTM or GDRX?

Do analysts rate HSTM or GDRX?

Does the media favor HSTM or GDRX?

Summary

How does HealthStream compare to Teladoc Health?

Which has more volatility & risk, HSTM or TDOC?

Which has better valuation and earnings, HSTM or TDOC?

Do institutionals and insiders have more ownership in HSTM or TDOC?

Does the media refer more to HSTM or TDOC?

Is HSTM or TDOC more profitable?

Do analysts recommend HSTM or TDOC?

Summary

How does HealthStream compare to SOPHiA GENETICS?

Which has more risk and volatility, SOPH or HSTM?

Which has higher earnings & valuation, SOPH or HSTM?

Do analysts prefer SOPH or HSTM?

Does the media refer more to SOPH or HSTM?

Do institutionals & insiders have more ownership in SOPH or HSTM?

Is SOPH or HSTM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSTM vs. The Competition

HealthStream Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools